BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28719505)

  • 1. Prevalence of Persistent Renal Dysfunction in Perinatally HIV-infected Thai Adolescents.
    Bunupuradah T; Phupitakphol T; Sophonphan J; Prasitsuebsai W; Anugulruengkitt S; Jantarabenjakul W; Sopa B; Ruxrungtham K; Chanakul A; Puthanakit T;
    Pediatr Infect Dis J; 2018 Jan; 37(1):66-70. PubMed ID: 28719505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function in Ethiopian HIV-positive adults on antiretroviral treatment with and without tenofovir.
    Yilma D; Abdissa A; Kæstel P; Tesfaye M; Olsen MF; Girma T; Ritz C; Friis H; Andersen ÅB; Kirk O
    BMC Infect Dis; 2020 Aug; 20(1):582. PubMed ID: 32762646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proximal renal tubular function in HIV-infected children on tenofovir disoproxil fumarate for treatment of HIV infection at two tertiary hospitals in Harare, Zimbabwe.
    Mashingaidze-Mano R; Bwakura-Dangarembizi MF; Maponga CC; Morse GD; Monera-Penduka TG; Mtisi TJ; Mudzviti T; Mujuru HA
    PLoS One; 2020; 15(7):e0235759. PubMed ID: 32634168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Dysfunction during Tenofovir Use in a Regional Cohort of HIV-Infected Individuals in the Asia-Pacific.
    Tanuma J; Jiamsakul A; Makane A; Avihingsanon A; Ng OT; Kiertiburanakul S; Chaiwarith R; Kumarasamy N; Nguyen KV; Pham TT; Lee MP; Ditangco R; Merati TP; Choi JY; Wong WW; Kamarulzaman A; Yunihastuti E; Sim BL; Ratanasuwan W; Kantipong P; Zhang F; Mustafa M; Saphonn V; Pujari S; Sohn AH;
    PLoS One; 2016; 11(8):e0161562. PubMed ID: 27560968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients.
    Quesada PR; Esteban LL; García JR; Sánchez RV; García TM; Alonso-Vega GG; Ferrández JS
    Int J Clin Pharm; 2015 Oct; 37(5):865-72. PubMed ID: 26008219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.
    Kooij KW; Vogt L; Wit FWNM; van der Valk M; van Zoest RA; Goorhuis A; Prins M; Post FA; Reiss P;
    J Infect Dis; 2017 Sep; 216(6):622-631. PubMed ID: 28934420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting.
    Kaboré NF; Poda A; Zoungrana J; Da O; Ciaffi L; Semdé A; Yaméogo I; Sawadogo AB; Delaporte E; Meda N; Limou S; Cournil A
    BMC Nephrol; 2019 May; 20(1):155. PubMed ID: 31064340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapy.
    Calza L; Sachs M; Colangeli V; Borderi M; Granozzi B; Malosso P; Comai G; Corradetti V; La Manna G; Viale P
    Clin Exp Nephrol; 2019 Nov; 23(11):1272-1279. PubMed ID: 31327092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal outcomes in patients initiated on tenofovir disoproxil fumarate-based antiretroviral therapy at a community health centre in Malawi.
    Chikwapulo B; Ngwira B; Sagno JB; Evans R
    Int J STD AIDS; 2018 Jun; 29(7):650-657. PubMed ID: 29334883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Abnormal Urine Protein/Osmolality Ratio Associated with Abnormal Renal Function in Patients Receiving Tenofovir Disoproxil Fumarate?
    Marcelin JR; Berg ML; Tan EM; Amer H; Cummins NW; Rizza SA
    PLoS One; 2016; 11(2):e0149562. PubMed ID: 26872144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of renal dysfunction among HIV infected patients receiving Tenofovir at Mulago: a cross-sectional study.
    Nyende L; Kalyesubula R; Sekasanvu E; Byakika-Kibwika P
    BMC Nephrol; 2020 Jun; 21(1):232. PubMed ID: 32571236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenofovir is associated with increased tubular proteinuria and asymptomatic renal tubular dysfunction in Ghana.
    Chadwick DR; Sarfo FS; Kirk ES; Owusu D; Bedu-Addo G; Parris V; Owusu AL; Phillips R
    BMC Nephrol; 2015 Dec; 16():195. PubMed ID: 26627687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubular and glomerular proteinuria in HIV-infected adults with estimated glomerular filtration rate ≥ 60 ml/min per 1.73 m2.
    Reynes J; Cournil A; Peyriere H; Psomas C; Guiller E; Chatron M; Cristol JP; Badiou S
    AIDS; 2013 May; 27(8):1295-302. PubMed ID: 23925378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of risk factors for chronic kidney disease in South African youth with perinatally acquired HIV.
    Frigati L; Mahtab S; Nourse P; Ray P; Perrazzo S; Machemedze T; Agyei NA; Cotton M; Myer L; Zar H
    Pediatr Nephrol; 2019 Feb; 34(2):313-318. PubMed ID: 30219929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Follow-Up of Proteinuria and Estimated Glomerular Filtration Rate in HIV-Infected Patients with Tubular Proteinuria.
    Peyriere H; Cournil A; Casanova ML; Badiou S; Cristol JP; Reynes J
    PLoS One; 2015; 10(11):e0142491. PubMed ID: 26571117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary β2 microglobulin can predict tenofovir disoproxil fumarate-related renal dysfunction in HIV-1-infected patients who initiate tenofovir disoproxil fumarate-containing antiretroviral therapy.
    Nishijima T; Kurosawa T; Tanaka N; Kawasaki Y; Kikuchi Y; Oka S; Gatanaga H
    AIDS; 2016 Jun; 30(10):1563-71. PubMed ID: 26919734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight: results from 10 years of follow-up.
    Nishijima T; Kawasaki Y; Tanaka N; Mizushima D; Aoki T; Watanabe K; Kinai E; Honda H; Yazaki H; Tanuma J; Tsukada K; Teruya K; Kikuchi Y; Gatanaga H; Oka S
    AIDS; 2014 Aug; 28(13):1903-10. PubMed ID: 25259702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Adverse Effects of Tenofovir Containing Regimens in HIV-Infected Children and Adolescents in North India.
    Kumar R; Singh MV; Shrivastava A; Yadav RK; Siddiqui SA; Sachan R; Maurya M; Mishra N; Shukla SK; Sonkar M
    Indian Pediatr; 2024 Apr; 61(4):337-342. PubMed ID: 38449277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in renal function with long-term exposure to antiretroviral therapy in HIV-infected adults in Asia.
    Joshi K; Boettiger D; Kerr S; Nishijima T; Van Nguyen K; Ly PS; Lee MP; Kumarasamy N; Wong W; Kantipong P; Cuong DD; Kamarulzaman A; Choi JY; Zhang F; Chaiwarith R; Ng OT; Kiertiburanakul S; Sim BLH; Merati TP; Yunihastuti E; Ditangco R; Ross J; Pujari S
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1209-1216. PubMed ID: 30246898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of Decline of Kidney Function in Human Immunodeficiency Virus-Infected Patients Under Routine Clinical Management.
    Boucquemont J; Lawson-Ayayi S; Rigothier C; Bonnet F; Proust-Lima C; Neau D; Greib C; Miremont-Salamé G; Dabis F; Dupon M; Dauchy FA;
    Nephron; 2017; 136(3):211-220. PubMed ID: 28445881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.